Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis

East Mediterr Health J. 2009 Nov-Dec;15(6):1346-50.

Abstract

We compared the effectiveness of 2 treatment regimens for isoniazid-resistant tuberculosis (TB) in 42 patients attending a TB referral centre in the Islamic Republic of Iran. The patients were divided into 2 treatment groups: 26 received the 6-month standard HRZE treatment and 16 received a modified treatment of RZE for 6 months. There were no significant differences in age or sex of the groups. With the standard method of treatment, 21 (80.8%) patients were cured, 4 (15.4%) resulted in treatment failure, and 1 (3.8%) died. In the modified treatment group, 16 (100%) patients were cured, These differences were not statistically significantly different (P = 0.194).

Publication types

  • Comparative Study

MeSH terms

  • Antitubercular Agents / therapeutic use*
  • Chi-Square Distribution
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Ethambutol / therapeutic use*
  • Female
  • Humans
  • Iran / epidemiology
  • Isoniazid / therapeutic use*
  • Male
  • Microbial Sensitivity Tests
  • Middle Aged
  • Pyrazinamide / therapeutic use*
  • Retrospective Studies
  • Rifampin / therapeutic use*
  • Sputum / microbiology
  • Streptomycin
  • Treatment Outcome
  • Tuberculosis, Pulmonary / drug therapy*
  • Tuberculosis, Pulmonary / epidemiology
  • Tuberculosis, Pulmonary / microbiology

Substances

  • Antitubercular Agents
  • Pyrazinamide
  • Ethambutol
  • Isoniazid
  • Rifampin
  • Streptomycin